Indranil Nandi

Indranil Nandi is Vice-President R&D for Impax Laboratories, a US based Specialty Pharmaceutical Company. He is responsible for managing CMC activities for generic and specialty branded products both internal and external development.

Prior to this position, Dr. Nandi was Executive Director of Portfolio, Project management and Scientific Affairs group at Sandoz, Inc. with the responsibility for managing more than 250 active projects in various stages of the development pipeline. He also served as a strategist in understanding interdependencies of scientific results and commercial possibilities and to utilize this knowledge to make appropriate business decisions for the US market.